Advertisement
Advertisement
TNXP
Tonix Pharmaceuticals Holding Corp.
15.74
USDSponsored
+1.65
+11.71%
May 15, 15:59 UTC -4
Closed
After-Market
15.60
-0.14
-0.89%
TNXP Earnings Reports
Positive Surprise Ratio
TNXP beat 21 of 42 last estimates.
50%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
$7.96M
/-$2.42
Implied change from Q1 26 (Revenue/ EPS)
+15.67%
/-17.41%
Implied change from Q2 25 (Revenue/ EPS)
+298.20%
/-37.31%
Tonix Pharmaceuticals Holding Corp. earnings per share and revenue
On May 11, 2026, TNXP reported earnings of -2.93 USD per share (EPS) for Q1 26, missing the estimate of -2.48 USD, resulting in a -18.05% surprise. Revenue reached 6.88 million, compared to an expected 6.25 million, with a 10.09% difference. The market reacted with a -5.88% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -2.42 USD, with revenue projected to reach 7.96 million USD, implying an decrease of -17.41% EPS, and increase of 15.67% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ARS Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.61
Surprise
-13.81%
ProKidney Corp. Class A Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+0.57%
Galectin Therapeutics Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.08
Surprise
-30.72%
NRX Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
$0.29
Actual
-$0.04
Surprise
-113.64%
Incannex Healthcare Limited - ADR
Report Date
May 15, 2026 For Q3 26
Estimate
-$0.94
Actual
-$11.22
Surprise
-1088.38%
Marker Therapeutics, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.44%
PLUS THERAPEUTICS, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.89
Actual
-$1.05
Surprise
-16.98%
VYNE Therapeutics Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.08
Surprise
+56.43%
Scienture Holdings, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.08
Surprise
+64.35%
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.77
Actual
-$1.28
Surprise
-65.12%
FAQ
What were Tonix Pharmaceuticals Holding Corp.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Tonix Pharmaceuticals Holding Corp. reported EPS of -$2.93, missing estimates by -18.05%, and revenue of $6.88M, 10.09% above expectations.
How did the market react to Tonix Pharmaceuticals Holding Corp.'s Q1 2026 earnings?
The stock price moved down -5.88%, changed from $14.11 before the earnings release to $13.28 the day after.
When is Tonix Pharmaceuticals Holding Corp. expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Tonix Pharmaceuticals Holding Corp.'s next earnings report?
Based on 3
analysts, Tonix Pharmaceuticals Holding Corp. is expected to report EPS of -$2.42 and revenue of $7.96M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement